Univo Pharmaceuticals

Univo Pharmaceuticals is a vertically integrated medical cannabis company based in Israel, with a comprehensive operational presence across the entire medical cannabis supply chain. The company's slogan "Providing top quality cannabis products to be used as the first choice of treatment" signifies its commitment to delivering high-quality cannabis products for medical purposes. With a deep understanding of patients’ needs, Univo has become the largest medical cannabis distributor in Israel, selling its products in over 100 pharmacies nationwide. The company's last investment was an ILS5.40MPost-IPO Equity investment from Cybele Holdings on 01 July 2019, indicating ongoing investor confidence in its operations. Led by CEO Golan Bitton and Chaired by Chaim Hurvitz, who brings substantial pharmaceutical leadership experience, Univo has positioned itself as a key player in the industry. The company’s focus on research, development, cultivation, and manufacturing of medical cannabis, along with a team of experts holding PhDs in relevant fields, reflects its commitment to innovation and product development. Univo's presence on the TASE TA-Cannabis Index further solidifies its standing in the market.